Cargando…

Novel Therapeutic Advances in β-Thalassemia

SIMPLE SUMMARY: Beta-thalassemia (β-thalassemia) is an autosomal recessive inherited disorder that causes decreased production of hemoglobin. Ineffective erythropoiesis and excess iron deposition are the most significant pathophysiological problems. Chronic red blood cell transfusions along with con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makis, Alexandros, Voskaridou, Ersi, Papassotiriou, Ioannis, Hatzimichael, Eleftheria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235056/ https://www.ncbi.nlm.nih.gov/pubmed/34207028 http://dx.doi.org/10.3390/biology10060546

Ejemplares similares

Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
por: Hatzimichael, Eleftheria, et al.
Publicado: (2022)

Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications
por: Georgoulis, Vasileios, et al.
Publicado: (2023)

Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia
por: Piga, Antonio, et al.
Publicado: (2022)

Recent advances in β-thalassemias
por: Cao, Antonio, et al.
Publicado: (2011)

Prognostic Factors for Immune Thrombocytopenia Outcome in Greek Children: A Retrospective Single-Centered Analysis
por: Makis, Alexandros, et al.
Publicado: (2017)

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study
por: Cappellini, Maria Domenica, et al.
Publicado: (2019)

Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review)
por: Amjad, Fareeha, et al.
Publicado: (2020)

Development of a High-Resolution Melting Approach for Scanning Beta Globin Gene Point Mutations in the Greek and Other Mediterranean Populations
por: Chassanidis, Christos, et al.
Publicado: (2016)

The therapeutic potential of genome editing for β-thalassemia
por: Glaser, Astrid, et al.
Publicado: (2015)

Identification and Functional Analysis of Known and New Mutations in the Transcription Factor KLF1 Linked with β-Thalassemia-like Phenotypes
por: Catapano, Rosa, et al.
Publicado: (2023)

Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
por: Zakaria, Nur Atikah, et al.
Publicado: (2021)

Hematopoietic stem cell transplantation
por: Hatzimichael, Eleftheria, et al.
Publicado: (2010)

Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients
por: Dranitsaris, George, et al.
Publicado: (2012)

Cancer Epigenetics: New Therapies and New Challenges
por: Hatzimichael, Eleftheria, et al.
Publicado: (2013)

Microenvironmental Features Driving Immune Evasion in Myelodysplastic Syndromes and Acute Myeloid Leukemia
por: Barakos, Georgios Petros, et al.
Publicado: (2022)

Profile of pacritinib and its potential in the treatment of hematologic disorders
por: Hatzimichael, Eleftheria, et al.
Publicado: (2014)

The Role of Non-Coding RNAs in Myelodysplastic Neoplasms
por: Georgoulis, Vasileios, et al.
Publicado: (2023)

Adverse Events Following COVID-19 Vaccination in Transfusion-Dependent -Thalassemia Patients
por: Delaporta, Polyxeni, et al.
Publicado: (2021)

The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34(+) Cells from Sickle Cell Disease Patients
por: Drakopoulou, Ekati, et al.
Publicado: (2022)

Ineffective Erythropoiesis in β-Thalassemia
por: Ribeil, Jean-Antoine, et al.
Publicado: (2013)

P111: COVID-19 IN PATIENTS WITH THALASSEMIA AND SICKLE CELL DISEASE: A SINGLE CENTER EXPERIENCE
por: Dimopoulou, M, et al.
Publicado: (2022)

Pathomechanisms of Immunological Disturbances in β-Thalassemia
por: Gluba-Brzózka, Anna, et al.
Publicado: (2021)

Nucleic Acid Therapy for β-Thalassemia
por: d’Arqom, Annette
Publicado: (2020)

Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy
por: Kanavaki, Aikaterini, et al.
Publicado: (2017)

Hyponatremia in Patients with Hematologic Diseases
por: Koumpis, Epameinondas, et al.
Publicado: (2020)

The role of epigenetics in childhood autoimmune diseases with hematological manifestations
por: Gkoutsias, Athanasios, et al.
Publicado: (2022)

Prenatal Diagnosis of β-Thalassemias and Hemoglobinopathies.
por: Rosatelli, Maria Cristina, et al.
Publicado: (2009)

Physiopathology of Bone Modifications in β-Thalassemia
por: Perisano, Carlo, et al.
Publicado: (2012)

Changing patterns in the epidemiology of β‐thalassemia
por: Kattamis, Antonis, et al.
Publicado: (2020)

Recent trends in the gene therapy of β-thalassemia
por: Finotti, Alessia, et al.
Publicado: (2015)

Recent advances in gene therapy for thalassemia
por: Raja, J. V., et al.
Publicado: (2012)

Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
por: Breda, Laura, et al.
Publicado: (2012)

Thalassemia and Nanotheragnostics: Advanced Approaches for Diagnosis and Treatment
por: Tariq, Zahra, et al.
Publicado: (2023)

Serum Lipids in Turkish Patients with β-Thalassemia Major and β-Thalassemia Minor
por: Işık Balcı, Yasemin, et al.
Publicado: (2016)

Real‐world complication burden and disease management paradigms in transfusion‐related β‐thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross‐sectional study
por: Kattamis, Antonis, et al.
Publicado: (2023)

The spectrum of β-thalassemia mutations in the Arab populations
por: Zahed, Laila
Publicado: (2001)

Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor
por: Breveglieri, Giulia, et al.
Publicado: (2019)

The Diverse Genomic Landscape of Diamond–Blackfan Anemia: Two Novel Variants and a Mini-Review
por: Pelagiadis, Iordanis, et al.
Publicado: (2023)

β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
por: Karimi, Mehran, et al.
Publicado: (2012)

Erythropoiesis In Vitro—A Research and Therapeutic Tool in Thalassemia
por: Fibach, Eitan
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m1k97hc3lubjpp2arg0eau84bt